Intercultural Management Final Assignment

-------------------------------------------------

-------------------------------------------------
Intercultural management
-------------------------------------------------

-------------------------------------------------
Final Assignment

Number of words | 3,666 |
-------------------------------------------------

-------------------------------------------------

Table of contents |

Introduction 3 The Novartis Company 3 1) Novartis’ presentation 3 a) Novartis in fact 3 b) Novartis’ CEO: Joseph Jimenez 4 c) Novartis’ chairman of the Board of Directors: Daniel Vasella 4 2) Novartis’ history and cultural background 4 3) Novartis’ industry: portfolio and mission 5 a) Pharmaceuticals 6 b) Alcon 6 c) Sandoz 6 d) Consumer health 6 e) Vaccines and Diagnostics 7 4) The Novartis’ intercultural characteristics 7 5) The intercultural context of Novartis 7 a) Agreement with the University of California Berkeley - 1998 8 b) Creation of Syngenta – 2000 8 c) Acquisition of Lek Pharmaceuticals – 2002 8 d) Creation of the Novartis Institutes for BioMedical research – 2002 8 e) Acquisition of Mead Johnson Company – 2003 9 f) Acquisition of Idenix – 2003 9 g) Acquisition of Durasacan – 2004 9 h) Acquisition of Hexal AG – 2005 9 i) Acquisition of Alcon – 2008 9 j) Acquisition of Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd. – 2009 9 k) Acquisition of Fougera Pharmaceuticals – 2012 10 Intercultural challenges within Novartis 10 1) The Novartis’ intercultural challenges 10 2) Novartis’ intercultural issues 11 a) The creation of Novartis 11 b) Patents’ law in India – 2006/2012 12 c) Purchases of companies and mergers 12 Recommendations 13 Conclusion 13 Bibliography 14

Introduction

In this final assignment of the Intercultural Management class, I will study the Novartis Company. This company is operating at an international level in the pharmaceutical

Bibliography: * BBC News Business. (2010, December 15). Novartis finalises Alcon Takeover worth $41 bn. BBC News . * Bloomberg Businessweek. (2012, July 23). Novartis Sandoz Unit Completes Fougera Purchase. Bloomberg Businessweek . * Boyd, R. (2005, February 2005). With $8.3 Billion Acquisition, Novartis is now Biggest Generic Drug Company. The New-York Sun . * Busch, L. (2007). Study of the University of California ar Berkeley Novartis Agreement. Retrieved January 02, 2013, from CS3.MSU.edu: http://cs3.msu.edu/research/project/berkeley-novartis/ * CNN Money * Distefano, J. J., & Maznevski, M. L. (2000). Creating Value with Diverse Teams in Global Management. Organizational Dynamics , 29, 45-63. * Diversity Journal. (2012, March 01). Joseph Jimenez - Novartis AG. Retrieved January 02, 2013, from Diversityjournal.com: http://www.diversityjournal.com/7695-joseph-jimenez-novartis-ag/ * DiversityInc * Idenix Pharmaceuticals . (2013). Corporate partners. Retrieved January 03, 2013, from Idenix.com: http://www.idenix.com/corporate/novartis.html * IMS Health * Lek pharmaceuticals. (2013). History. Retrieved January 03, 2013, from Lek.si: http://www.lek.si/en/about-us/history/ * More, K * Novartis. (2012). Company history. Retrieved January 02, 2013, from Novartis.com: http://www.novartis.com/about-novartis/company-history/index.shtml * Novartis * Novartis Institutes for BioMedical Research. (2013). About us. Retrieved January 03, 2013, from nibr.com: http://www.nibr.com/about/index.shtml * Novartis * Pollack, A. (2003, March 28). novartis to Acquire 51% of Idenix Pharmaceuticals. New-York Times . * Schuller, R. S., Jackson, S. E., & Luo, Y. (2004). Managing Human Resources in Cross-boarder Alliances. London, UK: Routledge. * Stahl, G. K., & Mendenhall, M. E. (2005). Mergers & Acquisitions: Managing Culture and Human Resources. Stanford, California, USA: Stanford University Press . * Syngenta. (2013). Company History. Retrieved January 02, 2013, from Syngenta.com: http://www.syngenta.com/global/corporate/en/about-syngenta/Pages/company-history.aspx * The Pharma Letter * Whitney, J. D. (1994). The Trust factor: Liberating Profits and Restoring Corporate vitality. New-York, NY, USA: McGraw-Hill. [ 2 ]. (CNN Money, 2012) [ 3 ] [ 4 ]. (Novartis, 2013) [ 5 ] [ 6 ]. (DiversityInc, 2012) [ 7 ] [ 8 ]. (Busch, 2007) [ 9 ] [ 10 ]. (Lek pharmaceuticals, 2013) [ 11 ] [ 12 ]. (Nutra Ingredients, 2003) [ 13 ] [ 14 ]. (Idenix Pharmaceuticals , 2013) [ 15 ] [ 16 ]. (Boyd, 2005) [ 17 ] [ 18 ]. (Novartis, 2011) [ 19 ] [ 20 ]. (Diversity Journal, 2012) [ 21 ] [ 22 ]. (Distefano & Maznevski, 2000) [ 23 ] [ 24 ]. (Stahl & Mendenhall, 2005) [ 25 ] [ 26 ]. (Oxfam International, 2012) [ 27 ]